Top GOP senator working on bipartisan drug price bill for mid-June

Top GOP senator working on bipartisan drug price bill for mid-June
© Greg Nash

Senate Finance Committee Chairman Chuck GrassleyCharles (Chuck) Ernest GrassleyAdvocates frustrated over pace of drug price reform Trump drug pricing setbacks put pressure on Congress Hillicon Valley: Trump rails against 'terrible bias' at White House social media summit | Twitter hit by hour-long outage | Google admits workers listen to smart device recordings MORE (R-Iowa) said this week that he is aiming to introduce bipartisan legislation by mid-June to lower drug prices.

Grassley, who made the announcement Thursday during a speech in Iowa, said he is working with the top Democrat on his committee, Sen. Ron WydenRonald (Ron) Lee WydenAdvocates frustrated over pace of drug price reform 2020 Democrats push tax hike on wealthy investors Hillicon Valley: FTC reportedly settles with Facebook for B fine | Trump calls to regulate Facebook's crypto project | Court rules Pentagon can award B 'war cloud' contract | Study shows automation will hit rural areas hardest MORE (Ore.), to try to find a path forward on an issue that is a priority for Democrats and President TrumpDonald John TrumpCNN's Camerota clashes with Trump's immigration head over president's tweet LA Times editorial board labels Trump 'Bigot-in-Chief' Trump complains of 'fake polls' after surveys show him trailing multiple Democratic candidates MORE.

ADVERTISEMENT
“We are writing legislation to address some of the systemic problems that make prescription drugs unaffordable for some Americans,” Grassley said in the speech, according to prepared remarks. “I expect that legislation to be ready for introduction in mid-June of this year.”

Wyden's office on Friday confirmed that the two senators are working together on a bill.

Grassley’s effort is being closely watched to see how far he will go in taking on drug companies to help lower prices. Grassley is well known for his willingness to support some legislation opposed by the pharmaceutical industry, but he has so far stopped short of endorsing Democrats’ No. 1 priority on the issue: allowing Medicare to negotiate drug prices.

Details are scant on the legislation Grassley and Wyden are working on.

The pair convened three hearings earlier this year to examine drug prices, including a high-profile event in February where drug company CEOs testified.

“I’ve heard from people all over the state of Iowa about high prescription drug prices,” Grassley said in Thursday's speech to the Global Insurance Symposium. “I’ve heard stories of people leaving their prescriptions at the drug store counter or rationing their insulin in order to make ends meet. Both of these are prescriptions for bad health care outcomes.”